Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
KriyaBio is an innovative biopharmaceutical company registered in Basel, Switzerland, focusing on developing innovative drug delivery technology platforms that improve drug bioavailability. Its core technology is KB01, a drug penetration enhancer that is currently in the patent application stage. By regulating cellular tight junctions, KB01 promotes the absorption of co-administered therapeutics, enabling active pharmaceutical ingredients (APIs) that originally require injection to be absorbed through the mucous membrane, thereby replacing injection administration.
The core value of this technology approach is very clear: on one hand, it converts invasive injection administration into non-invasive administration, greatly improving patient medication adherence; on the other hand, it also reduces the overall cost of drug manufacturing and healthcare. The business covers two types of cooperation scenarios: it helps partners enrich their early-stage drug pipelines, and also supports established pharmaceutical companies in conducting life cycle management and market expansion for existing marketed products. Its lineup of team members is its core advantage: most core members come from top global pharmaceutical companies including Roche, Merck, and Lonza, covering the entire chain of R&D, clinical research, compliance, and finance, with deep industry experience.
Currently, the website only offers open cooperation inquiries, with no specific information such as pricing or commercialized products disclosed publicly. Technical details are also limited, so it is not suitable for individual developers or small teams for rapid docking.
This website opens cooperation inquiries to global pharmaceutical companies, and can be accessed directly by Chinese users. It is suitable for domestic biopharmaceutical companies with demand for drug delivery modification to connect for cooperation.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on kriyabio.com official site.
kriyabio.com is an overseas Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach kriyabio.com directly.